Global Targeted Drugs for Colorectal Cancer Supply, Demand and Key Producers, 2023-2029
The global Targeted Drugs for Colorectal Cancer market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
This report studies the global Targeted Drugs for Colorectal Cancer production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Drugs for Colorectal Cancer, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Drugs for Colorectal Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted Drugs for Colorectal Cancer total production and demand, 2018-2029, (K Units)
Global Targeted Drugs for Colorectal Cancer total production value, 2018-2029, (USD Million)
Global Targeted Drugs for Colorectal Cancer production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Drugs for Colorectal Cancer consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Targeted Drugs for Colorectal Cancer domestic production, consumption, key domestic manufacturers and share
Global Targeted Drugs for Colorectal Cancer production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Targeted Drugs for Colorectal Cancer production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Drugs for Colorectal Cancer production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Targeted Drugs for Colorectal Cancer market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Amgen, F. Hoffmann-La Roche Ltd, Novartis, Array BioPharma, Genentech, Bayer, Sanofi and Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Drugs for Colorectal Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Targeted Drugs for Colorectal Cancer Market, By Region:
1. How big is the global Targeted Drugs for Colorectal Cancer market?
2. What is the demand of the global Targeted Drugs for Colorectal Cancer market?
3. What is the year over year growth of the global Targeted Drugs for Colorectal Cancer market?
4. What is the production and production value of the global Targeted Drugs for Colorectal Cancer market?
5. Who are the key producers in the global Targeted Drugs for Colorectal Cancer market?
6. What are the growth factors driving the market demand?
Targeted therapy is to design corresponding therapeutic drugs for the identified cancer-causing site (the site can be a protein molecule inside the tumor cell or a gene fragment) at the cellular molecular level, and the drug enters the body It will specifically select oncogenic sites to combine and act, so that tumor cells will die specifically, without affecting normal tissue cells around the tumor.
This report studies the global Targeted Drugs for Colorectal Cancer production, demand, key manufacturers, and key regions.
This report is a detailed and comprehensive analysis of the world market for Targeted Drugs for Colorectal Cancer, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Targeted Drugs for Colorectal Cancer that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Targeted Drugs for Colorectal Cancer total production and demand, 2018-2029, (K Units)
Global Targeted Drugs for Colorectal Cancer total production value, 2018-2029, (USD Million)
Global Targeted Drugs for Colorectal Cancer production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Drugs for Colorectal Cancer consumption by region & country, CAGR, 2018-2029 & (K Units)
U.S. VS China: Targeted Drugs for Colorectal Cancer domestic production, consumption, key domestic manufacturers and share
Global Targeted Drugs for Colorectal Cancer production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)
Global Targeted Drugs for Colorectal Cancer production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)
Global Targeted Drugs for Colorectal Cancer production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)
This reports profiles key players in the global Targeted Drugs for Colorectal Cancer market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Amgen, F. Hoffmann-La Roche Ltd, Novartis, Array BioPharma, Genentech, Bayer, Sanofi and Lilly, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Targeted Drugs for Colorectal Cancer market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Targeted Drugs for Colorectal Cancer Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- EGFR Target
- BRAF Target
- MEK1/2 Targets
- BRAF V600 Target
- HER2 Target
- VEGFR-1/2/3 Targets
- PD-1 Target
- CTLA-4 Target
- Hospital
- Specialty Clinic
- Merck
- Amgen
- F. Hoffmann-La Roche Ltd
- Novartis
- Array BioPharma
- Genentech
- Bayer
- Sanofi
- Lilly
- Bristol myers squibb
- MSD lreland
- HUTCHMED
1. How big is the global Targeted Drugs for Colorectal Cancer market?
2. What is the demand of the global Targeted Drugs for Colorectal Cancer market?
3. What is the year over year growth of the global Targeted Drugs for Colorectal Cancer market?
4. What is the production and production value of the global Targeted Drugs for Colorectal Cancer market?
5. Who are the key producers in the global Targeted Drugs for Colorectal Cancer market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Targeted Drugs for Colorectal Cancer Introduction
1.2 World Targeted Drugs for Colorectal Cancer Supply & Forecast
1.2.1 World Targeted Drugs for Colorectal Cancer Production Value (2018 & 2022 & 2029)
1.2.2 World Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.2.3 World Targeted Drugs for Colorectal Cancer Pricing Trends (2018-2029)
1.3 World Targeted Drugs for Colorectal Cancer Production by Region (Based on Production Site)
1.3.1 World Targeted Drugs for Colorectal Cancer Production Value by Region (2018-2029)
1.3.2 World Targeted Drugs for Colorectal Cancer Production by Region (2018-2029)
1.3.3 World Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2029)
1.3.4 North America Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.3.5 Europe Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.3.6 China Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.3.7 Japan Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Drugs for Colorectal Cancer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Drugs for Colorectal Cancer Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Targeted Drugs for Colorectal Cancer Demand (2018-2029)
2.2 World Targeted Drugs for Colorectal Cancer Consumption by Region
2.2.1 World Targeted Drugs for Colorectal Cancer Consumption by Region (2018-2023)
2.2.2 World Targeted Drugs for Colorectal Cancer Consumption Forecast by Region (2024-2029)
2.3 United States Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.4 China Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.5 Europe Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.6 Japan Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.7 South Korea Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.8 ASEAN Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.9 India Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
3 WORLD TARGETED DRUGS FOR COLORECTAL CANCER MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Targeted Drugs for Colorectal Cancer Production Value by Manufacturer (2018-2023)
3.2 World Targeted Drugs for Colorectal Cancer Production by Manufacturer (2018-2023)
3.3 World Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023)
3.4 Targeted Drugs for Colorectal Cancer Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Targeted Drugs for Colorectal Cancer Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Targeted Drugs for Colorectal Cancer in 2022
3.5.3 Global Concentration Ratios (CR8) for Targeted Drugs for Colorectal Cancer in 2022
3.6 Targeted Drugs for Colorectal Cancer Market: Overall Company Footprint Analysis
3.6.1 Targeted Drugs for Colorectal Cancer Market: Region Footprint
3.6.2 Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
3.6.3 Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Targeted Drugs for Colorectal Cancer Production Value Comparison
4.1.1 United States VS China: Targeted Drugs for Colorectal Cancer Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Targeted Drugs for Colorectal Cancer Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Targeted Drugs for Colorectal Cancer Production Comparison
4.2.1 United States VS China: Targeted Drugs for Colorectal Cancer Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Targeted Drugs for Colorectal Cancer Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Targeted Drugs for Colorectal Cancer Consumption Comparison
4.3.1 United States VS China: Targeted Drugs for Colorectal Cancer Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Targeted Drugs for Colorectal Cancer Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Targeted Drugs for Colorectal Cancer Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value (2018-2023)
4.4.3 United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023)
4.5 China Based Targeted Drugs for Colorectal Cancer Manufacturers and Market Share
4.5.1 China Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value (2018-2023)
4.5.3 China Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023)
4.6 Rest of World Based Targeted Drugs for Colorectal Cancer Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Drugs for Colorectal Cancer Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 EGFR Target
5.2.2 BRAF Target
5.2.3 MEK1/2 Targets
5.2.4 BRAF V600 Target
5.2.5 HER2 Target
5.2.6 VEGFR-1/2/3 Targets
5.2.7 PD-1 Target
5.2.8 CTLA-4 Target
5.3 Market Segment by Type
5.3.1 World Targeted Drugs for Colorectal Cancer Production by Type (2018-2029)
5.3.2 World Targeted Drugs for Colorectal Cancer Production Value by Type (2018-2029)
5.3.3 World Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Drugs for Colorectal Cancer Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialty Clinic
6.3 Market Segment by Application
6.3.1 World Targeted Drugs for Colorectal Cancer Production by Application (2018-2029)
6.3.2 World Targeted Drugs for Colorectal Cancer Production Value by Application (2018-2029)
6.3.3 World Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Targeted Drugs for Colorectal Cancer Product and Services
7.1.4 Merck Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Targeted Drugs for Colorectal Cancer Product and Services
7.2.4 Amgen Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Details
7.3.2 F. Hoffmann-La Roche Ltd Major Business
7.3.3 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
7.3.4 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.3.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Targeted Drugs for Colorectal Cancer Product and Services
7.4.4 Novartis Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Array BioPharma
7.5.1 Array BioPharma Details
7.5.2 Array BioPharma Major Business
7.5.3 Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
7.5.4 Array BioPharma Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Array BioPharma Recent Developments/Updates
7.5.6 Array BioPharma Competitive Strengths & Weaknesses
7.6 Genentech
7.6.1 Genentech Details
7.6.2 Genentech Major Business
7.6.3 Genentech Targeted Drugs for Colorectal Cancer Product and Services
7.6.4 Genentech Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Genentech Recent Developments/Updates
7.6.6 Genentech Competitive Strengths & Weaknesses
7.7 Bayer
7.7.1 Bayer Details
7.7.2 Bayer Major Business
7.7.3 Bayer Targeted Drugs for Colorectal Cancer Product and Services
7.7.4 Bayer Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bayer Recent Developments/Updates
7.7.6 Bayer Competitive Strengths & Weaknesses
7.8 Sanofi
7.8.1 Sanofi Details
7.8.2 Sanofi Major Business
7.8.3 Sanofi Targeted Drugs for Colorectal Cancer Product and Services
7.8.4 Sanofi Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sanofi Recent Developments/Updates
7.8.6 Sanofi Competitive Strengths & Weaknesses
7.9 Lilly
7.9.1 Lilly Details
7.9.2 Lilly Major Business
7.9.3 Lilly Targeted Drugs for Colorectal Cancer Product and Services
7.9.4 Lilly Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Lilly Recent Developments/Updates
7.9.6 Lilly Competitive Strengths & Weaknesses
7.10 Bristol myers squibb
7.10.1 Bristol myers squibb Details
7.10.2 Bristol myers squibb Major Business
7.10.3 Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
7.10.4 Bristol myers squibb Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bristol myers squibb Recent Developments/Updates
7.10.6 Bristol myers squibb Competitive Strengths & Weaknesses
7.11 MSD lreland
7.11.1 MSD lreland Details
7.11.2 MSD lreland Major Business
7.11.3 MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
7.11.4 MSD lreland Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 MSD lreland Recent Developments/Updates
7.11.6 MSD lreland Competitive Strengths & Weaknesses
7.12 HUTCHMED
7.12.1 HUTCHMED Details
7.12.2 HUTCHMED Major Business
7.12.3 HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
7.12.4 HUTCHMED Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 HUTCHMED Recent Developments/Updates
7.12.6 HUTCHMED Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Targeted Drugs for Colorectal Cancer Industry Chain
8.2 Targeted Drugs for Colorectal Cancer Upstream Analysis
8.2.1 Targeted Drugs for Colorectal Cancer Core Raw Materials
8.2.2 Main Manufacturers of Targeted Drugs for Colorectal Cancer Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Targeted Drugs for Colorectal Cancer Production Mode
8.6 Targeted Drugs for Colorectal Cancer Procurement Model
8.7 Targeted Drugs for Colorectal Cancer Industry Sales Model and Sales Channels
8.7.1 Targeted Drugs for Colorectal Cancer Sales Model
8.7.2 Targeted Drugs for Colorectal Cancer Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Targeted Drugs for Colorectal Cancer Introduction
1.2 World Targeted Drugs for Colorectal Cancer Supply & Forecast
1.2.1 World Targeted Drugs for Colorectal Cancer Production Value (2018 & 2022 & 2029)
1.2.2 World Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.2.3 World Targeted Drugs for Colorectal Cancer Pricing Trends (2018-2029)
1.3 World Targeted Drugs for Colorectal Cancer Production by Region (Based on Production Site)
1.3.1 World Targeted Drugs for Colorectal Cancer Production Value by Region (2018-2029)
1.3.2 World Targeted Drugs for Colorectal Cancer Production by Region (2018-2029)
1.3.3 World Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2029)
1.3.4 North America Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.3.5 Europe Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.3.6 China Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.3.7 Japan Targeted Drugs for Colorectal Cancer Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Targeted Drugs for Colorectal Cancer Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Targeted Drugs for Colorectal Cancer Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Targeted Drugs for Colorectal Cancer Demand (2018-2029)
2.2 World Targeted Drugs for Colorectal Cancer Consumption by Region
2.2.1 World Targeted Drugs for Colorectal Cancer Consumption by Region (2018-2023)
2.2.2 World Targeted Drugs for Colorectal Cancer Consumption Forecast by Region (2024-2029)
2.3 United States Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.4 China Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.5 Europe Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.6 Japan Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.7 South Korea Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.8 ASEAN Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
2.9 India Targeted Drugs for Colorectal Cancer Consumption (2018-2029)
3 WORLD TARGETED DRUGS FOR COLORECTAL CANCER MANUFACTURERS COMPETITIVE ANALYSIS
3.1 World Targeted Drugs for Colorectal Cancer Production Value by Manufacturer (2018-2023)
3.2 World Targeted Drugs for Colorectal Cancer Production by Manufacturer (2018-2023)
3.3 World Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023)
3.4 Targeted Drugs for Colorectal Cancer Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
3.5.1 Global Targeted Drugs for Colorectal Cancer Industry Rank of Major Manufacturers
3.5.2 Global Concentration Ratios (CR4) for Targeted Drugs for Colorectal Cancer in 2022
3.5.3 Global Concentration Ratios (CR8) for Targeted Drugs for Colorectal Cancer in 2022
3.6 Targeted Drugs for Colorectal Cancer Market: Overall Company Footprint Analysis
3.6.1 Targeted Drugs for Colorectal Cancer Market: Region Footprint
3.6.2 Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
3.6.3 Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
3.7 Competitive Environment
3.7.1 Historical Structure of the Industry
3.7.2 Barriers of Market Entry
3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations
4 UNITED STATES VS CHINA VS REST OF THE WORLD
4.1 United States VS China: Targeted Drugs for Colorectal Cancer Production Value Comparison
4.1.1 United States VS China: Targeted Drugs for Colorectal Cancer Production Value Comparison (2018 & 2022 & 2029)
4.1.2 United States VS China: Targeted Drugs for Colorectal Cancer Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Targeted Drugs for Colorectal Cancer Production Comparison
4.2.1 United States VS China: Targeted Drugs for Colorectal Cancer Production Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Targeted Drugs for Colorectal Cancer Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Targeted Drugs for Colorectal Cancer Consumption Comparison
4.3.1 United States VS China: Targeted Drugs for Colorectal Cancer Consumption Comparison (2018 & 2022 & 2029)
4.3.2 United States VS China: Targeted Drugs for Colorectal Cancer Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Targeted Drugs for Colorectal Cancer Manufacturers and Market Share, 2018-2023
4.4.1 United States Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (States, Country)
4.4.2 United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value (2018-2023)
4.4.3 United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023)
4.5 China Based Targeted Drugs for Colorectal Cancer Manufacturers and Market Share
4.5.1 China Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (Province, Country)
4.5.2 China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value (2018-2023)
4.5.3 China Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023)
4.6 Rest of World Based Targeted Drugs for Colorectal Cancer Manufacturers and Market Share, 2018-2023
4.6.1 Rest of World Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (State, Country)
4.6.2 Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value (2018-2023)
4.6.3 Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Targeted Drugs for Colorectal Cancer Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 EGFR Target
5.2.2 BRAF Target
5.2.3 MEK1/2 Targets
5.2.4 BRAF V600 Target
5.2.5 HER2 Target
5.2.6 VEGFR-1/2/3 Targets
5.2.7 PD-1 Target
5.2.8 CTLA-4 Target
5.3 Market Segment by Type
5.3.1 World Targeted Drugs for Colorectal Cancer Production by Type (2018-2029)
5.3.2 World Targeted Drugs for Colorectal Cancer Production Value by Type (2018-2029)
5.3.3 World Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Targeted Drugs for Colorectal Cancer Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Specialty Clinic
6.3 Market Segment by Application
6.3.1 World Targeted Drugs for Colorectal Cancer Production by Application (2018-2029)
6.3.2 World Targeted Drugs for Colorectal Cancer Production Value by Application (2018-2029)
6.3.3 World Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029)
7 COMPANY PROFILES
7.1 Merck
7.1.1 Merck Details
7.1.2 Merck Major Business
7.1.3 Merck Targeted Drugs for Colorectal Cancer Product and Services
7.1.4 Merck Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.1.5 Merck Recent Developments/Updates
7.1.6 Merck Competitive Strengths & Weaknesses
7.2 Amgen
7.2.1 Amgen Details
7.2.2 Amgen Major Business
7.2.3 Amgen Targeted Drugs for Colorectal Cancer Product and Services
7.2.4 Amgen Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.2.5 Amgen Recent Developments/Updates
7.2.6 Amgen Competitive Strengths & Weaknesses
7.3 F. Hoffmann-La Roche Ltd
7.3.1 F. Hoffmann-La Roche Ltd Details
7.3.2 F. Hoffmann-La Roche Ltd Major Business
7.3.3 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
7.3.4 F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.3.5 F. Hoffmann-La Roche Ltd Recent Developments/Updates
7.3.6 F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
7.4 Novartis
7.4.1 Novartis Details
7.4.2 Novartis Major Business
7.4.3 Novartis Targeted Drugs for Colorectal Cancer Product and Services
7.4.4 Novartis Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.4.5 Novartis Recent Developments/Updates
7.4.6 Novartis Competitive Strengths & Weaknesses
7.5 Array BioPharma
7.5.1 Array BioPharma Details
7.5.2 Array BioPharma Major Business
7.5.3 Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
7.5.4 Array BioPharma Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.5.5 Array BioPharma Recent Developments/Updates
7.5.6 Array BioPharma Competitive Strengths & Weaknesses
7.6 Genentech
7.6.1 Genentech Details
7.6.2 Genentech Major Business
7.6.3 Genentech Targeted Drugs for Colorectal Cancer Product and Services
7.6.4 Genentech Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.6.5 Genentech Recent Developments/Updates
7.6.6 Genentech Competitive Strengths & Weaknesses
7.7 Bayer
7.7.1 Bayer Details
7.7.2 Bayer Major Business
7.7.3 Bayer Targeted Drugs for Colorectal Cancer Product and Services
7.7.4 Bayer Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.7.5 Bayer Recent Developments/Updates
7.7.6 Bayer Competitive Strengths & Weaknesses
7.8 Sanofi
7.8.1 Sanofi Details
7.8.2 Sanofi Major Business
7.8.3 Sanofi Targeted Drugs for Colorectal Cancer Product and Services
7.8.4 Sanofi Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.8.5 Sanofi Recent Developments/Updates
7.8.6 Sanofi Competitive Strengths & Weaknesses
7.9 Lilly
7.9.1 Lilly Details
7.9.2 Lilly Major Business
7.9.3 Lilly Targeted Drugs for Colorectal Cancer Product and Services
7.9.4 Lilly Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.9.5 Lilly Recent Developments/Updates
7.9.6 Lilly Competitive Strengths & Weaknesses
7.10 Bristol myers squibb
7.10.1 Bristol myers squibb Details
7.10.2 Bristol myers squibb Major Business
7.10.3 Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
7.10.4 Bristol myers squibb Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.10.5 Bristol myers squibb Recent Developments/Updates
7.10.6 Bristol myers squibb Competitive Strengths & Weaknesses
7.11 MSD lreland
7.11.1 MSD lreland Details
7.11.2 MSD lreland Major Business
7.11.3 MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
7.11.4 MSD lreland Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.11.5 MSD lreland Recent Developments/Updates
7.11.6 MSD lreland Competitive Strengths & Weaknesses
7.12 HUTCHMED
7.12.1 HUTCHMED Details
7.12.2 HUTCHMED Major Business
7.12.3 HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
7.12.4 HUTCHMED Targeted Drugs for Colorectal Cancer Production, Price, Value, Gross Margin and Market Share (2018-2023)
7.12.5 HUTCHMED Recent Developments/Updates
7.12.6 HUTCHMED Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Targeted Drugs for Colorectal Cancer Industry Chain
8.2 Targeted Drugs for Colorectal Cancer Upstream Analysis
8.2.1 Targeted Drugs for Colorectal Cancer Core Raw Materials
8.2.2 Main Manufacturers of Targeted Drugs for Colorectal Cancer Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Targeted Drugs for Colorectal Cancer Production Mode
8.6 Targeted Drugs for Colorectal Cancer Procurement Model
8.7 Targeted Drugs for Colorectal Cancer Industry Sales Model and Sales Channels
8.7.1 Targeted Drugs for Colorectal Cancer Sales Model
8.7.2 Targeted Drugs for Colorectal Cancer Typical Customers
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Targeted Drugs for Colorectal Cancer Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Targeted Drugs for Colorectal Cancer Production Value by Region (2018-2023) & (USD Million)
Table 3. World Targeted Drugs for Colorectal Cancer Production Value by Region (2024-2029) & (USD Million)
Table 4. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Region (2018-2023)
Table 5. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Region (2024-2029)
Table 6. World Targeted Drugs for Colorectal Cancer Production by Region (2018-2023) & (K Units)
Table 7. World Targeted Drugs for Colorectal Cancer Production by Region (2024-2029) & (K Units)
Table 8. World Targeted Drugs for Colorectal Cancer Production Market Share by Region (2018-2023)
Table 9. World Targeted Drugs for Colorectal Cancer Production Market Share by Region (2024-2029)
Table 10. World Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Targeted Drugs for Colorectal Cancer Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Targeted Drugs for Colorectal Cancer Major Market Trends
Table 13. World Targeted Drugs for Colorectal Cancer Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Targeted Drugs for Colorectal Cancer Consumption by Region (2018-2023) & (K Units)
Table 15. World Targeted Drugs for Colorectal Cancer Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Targeted Drugs for Colorectal Cancer Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Targeted Drugs for Colorectal Cancer Producers in 2022
Table 18. World Targeted Drugs for Colorectal Cancer Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Targeted Drugs for Colorectal Cancer Producers in 2022
Table 20. World Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Targeted Drugs for Colorectal Cancer Company Evaluation Quadrant
Table 22. World Targeted Drugs for Colorectal Cancer Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Targeted Drugs for Colorectal Cancer Production Site of Key Manufacturer
Table 24. Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
Table 25. Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
Table 26. Targeted Drugs for Colorectal Cancer Competitive Factors
Table 27. Targeted Drugs for Colorectal Cancer New Entrant and Capacity Expansion Plans
Table 28. Targeted Drugs for Colorectal Cancer Mergers & Acquisitions Activity
Table 29. United States VS China Targeted Drugs for Colorectal Cancer Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Targeted Drugs for Colorectal Cancer Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Targeted Drugs for Colorectal Cancer Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share (2018-2023)
Table 37. China Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share (2018-2023)
Table 42. Rest of World Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share (2018-2023)
Table 47. World Targeted Drugs for Colorectal Cancer Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Targeted Drugs for Colorectal Cancer Production by Type (2018-2023) & (K Units)
Table 49. World Targeted Drugs for Colorectal Cancer Production by Type (2024-2029) & (K Units)
Table 50. World Targeted Drugs for Colorectal Cancer Production Value by Type (2018-2023) & (USD Million)
Table 51. World Targeted Drugs for Colorectal Cancer Production Value by Type (2024-2029) & (USD Million)
Table 52. World Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Targeted Drugs for Colorectal Cancer Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Targeted Drugs for Colorectal Cancer Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Targeted Drugs for Colorectal Cancer Production by Application (2018-2023) & (K Units)
Table 56. World Targeted Drugs for Colorectal Cancer Production by Application (2024-2029) & (K Units)
Table 57. World Targeted Drugs for Colorectal Cancer Production Value by Application (2018-2023) & (USD Million)
Table 58. World Targeted Drugs for Colorectal Cancer Production Value by Application (2024-2029) & (USD Million)
Table 59. World Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Targeted Drugs for Colorectal Cancer Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Targeted Drugs for Colorectal Cancer Product and Services
Table 64. Merck Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Targeted Drugs for Colorectal Cancer Product and Services
Table 70. Amgen Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 74. F. Hoffmann-La Roche Ltd Major Business
Table 75. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
Table 76. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 78. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Targeted Drugs for Colorectal Cancer Product and Services
Table 82. Novartis Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Array BioPharma Basic Information, Manufacturing Base and Competitors
Table 86. Array BioPharma Major Business
Table 87. Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
Table 88. Array BioPharma Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Array BioPharma Recent Developments/Updates
Table 90. Array BioPharma Competitive Strengths & Weaknesses
Table 91. Genentech Basic Information, Manufacturing Base and Competitors
Table 92. Genentech Major Business
Table 93. Genentech Targeted Drugs for Colorectal Cancer Product and Services
Table 94. Genentech Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Genentech Recent Developments/Updates
Table 96. Genentech Competitive Strengths & Weaknesses
Table 97. Bayer Basic Information, Manufacturing Base and Competitors
Table 98. Bayer Major Business
Table 99. Bayer Targeted Drugs for Colorectal Cancer Product and Services
Table 100. Bayer Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bayer Recent Developments/Updates
Table 102. Bayer Competitive Strengths & Weaknesses
Table 103. Sanofi Basic Information, Manufacturing Base and Competitors
Table 104. Sanofi Major Business
Table 105. Sanofi Targeted Drugs for Colorectal Cancer Product and Services
Table 106. Sanofi Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sanofi Recent Developments/Updates
Table 108. Sanofi Competitive Strengths & Weaknesses
Table 109. Lilly Basic Information, Manufacturing Base and Competitors
Table 110. Lilly Major Business
Table 111. Lilly Targeted Drugs for Colorectal Cancer Product and Services
Table 112. Lilly Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Lilly Recent Developments/Updates
Table 114. Lilly Competitive Strengths & Weaknesses
Table 115. Bristol myers squibb Basic Information, Manufacturing Base and Competitors
Table 116. Bristol myers squibb Major Business
Table 117. Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
Table 118. Bristol myers squibb Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bristol myers squibb Recent Developments/Updates
Table 120. Bristol myers squibb Competitive Strengths & Weaknesses
Table 121. MSD lreland Basic Information, Manufacturing Base and Competitors
Table 122. MSD lreland Major Business
Table 123. MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
Table 124. MSD lreland Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. MSD lreland Recent Developments/Updates
Table 126. HUTCHMED Basic Information, Manufacturing Base and Competitors
Table 127. HUTCHMED Major Business
Table 128. HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
Table 129. HUTCHMED Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Targeted Drugs for Colorectal Cancer Upstream (Raw Materials)
Table 131. Targeted Drugs for Colorectal Cancer Typical Customers
Table 132. Targeted Drugs for Colorectal Cancer Typical Distributors
Table 1. World Targeted Drugs for Colorectal Cancer Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Targeted Drugs for Colorectal Cancer Production Value by Region (2018-2023) & (USD Million)
Table 3. World Targeted Drugs for Colorectal Cancer Production Value by Region (2024-2029) & (USD Million)
Table 4. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Region (2018-2023)
Table 5. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Region (2024-2029)
Table 6. World Targeted Drugs for Colorectal Cancer Production by Region (2018-2023) & (K Units)
Table 7. World Targeted Drugs for Colorectal Cancer Production by Region (2024-2029) & (K Units)
Table 8. World Targeted Drugs for Colorectal Cancer Production Market Share by Region (2018-2023)
Table 9. World Targeted Drugs for Colorectal Cancer Production Market Share by Region (2024-2029)
Table 10. World Targeted Drugs for Colorectal Cancer Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Targeted Drugs for Colorectal Cancer Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Targeted Drugs for Colorectal Cancer Major Market Trends
Table 13. World Targeted Drugs for Colorectal Cancer Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Targeted Drugs for Colorectal Cancer Consumption by Region (2018-2023) & (K Units)
Table 15. World Targeted Drugs for Colorectal Cancer Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Targeted Drugs for Colorectal Cancer Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Targeted Drugs for Colorectal Cancer Producers in 2022
Table 18. World Targeted Drugs for Colorectal Cancer Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Targeted Drugs for Colorectal Cancer Producers in 2022
Table 20. World Targeted Drugs for Colorectal Cancer Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Targeted Drugs for Colorectal Cancer Company Evaluation Quadrant
Table 22. World Targeted Drugs for Colorectal Cancer Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Targeted Drugs for Colorectal Cancer Production Site of Key Manufacturer
Table 24. Targeted Drugs for Colorectal Cancer Market: Company Product Type Footprint
Table 25. Targeted Drugs for Colorectal Cancer Market: Company Product Application Footprint
Table 26. Targeted Drugs for Colorectal Cancer Competitive Factors
Table 27. Targeted Drugs for Colorectal Cancer New Entrant and Capacity Expansion Plans
Table 28. Targeted Drugs for Colorectal Cancer Mergers & Acquisitions Activity
Table 29. United States VS China Targeted Drugs for Colorectal Cancer Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Targeted Drugs for Colorectal Cancer Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Targeted Drugs for Colorectal Cancer Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share (2018-2023)
Table 37. China Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share (2018-2023)
Table 42. Rest of World Based Targeted Drugs for Colorectal Cancer Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share (2018-2023)
Table 47. World Targeted Drugs for Colorectal Cancer Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Targeted Drugs for Colorectal Cancer Production by Type (2018-2023) & (K Units)
Table 49. World Targeted Drugs for Colorectal Cancer Production by Type (2024-2029) & (K Units)
Table 50. World Targeted Drugs for Colorectal Cancer Production Value by Type (2018-2023) & (USD Million)
Table 51. World Targeted Drugs for Colorectal Cancer Production Value by Type (2024-2029) & (USD Million)
Table 52. World Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Targeted Drugs for Colorectal Cancer Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Targeted Drugs for Colorectal Cancer Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Targeted Drugs for Colorectal Cancer Production by Application (2018-2023) & (K Units)
Table 56. World Targeted Drugs for Colorectal Cancer Production by Application (2024-2029) & (K Units)
Table 57. World Targeted Drugs for Colorectal Cancer Production Value by Application (2018-2023) & (USD Million)
Table 58. World Targeted Drugs for Colorectal Cancer Production Value by Application (2024-2029) & (USD Million)
Table 59. World Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Targeted Drugs for Colorectal Cancer Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Merck Basic Information, Manufacturing Base and Competitors
Table 62. Merck Major Business
Table 63. Merck Targeted Drugs for Colorectal Cancer Product and Services
Table 64. Merck Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Merck Recent Developments/Updates
Table 66. Merck Competitive Strengths & Weaknesses
Table 67. Amgen Basic Information, Manufacturing Base and Competitors
Table 68. Amgen Major Business
Table 69. Amgen Targeted Drugs for Colorectal Cancer Product and Services
Table 70. Amgen Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Amgen Recent Developments/Updates
Table 72. Amgen Competitive Strengths & Weaknesses
Table 73. F. Hoffmann-La Roche Ltd Basic Information, Manufacturing Base and Competitors
Table 74. F. Hoffmann-La Roche Ltd Major Business
Table 75. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Product and Services
Table 76. F. Hoffmann-La Roche Ltd Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. F. Hoffmann-La Roche Ltd Recent Developments/Updates
Table 78. F. Hoffmann-La Roche Ltd Competitive Strengths & Weaknesses
Table 79. Novartis Basic Information, Manufacturing Base and Competitors
Table 80. Novartis Major Business
Table 81. Novartis Targeted Drugs for Colorectal Cancer Product and Services
Table 82. Novartis Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Novartis Recent Developments/Updates
Table 84. Novartis Competitive Strengths & Weaknesses
Table 85. Array BioPharma Basic Information, Manufacturing Base and Competitors
Table 86. Array BioPharma Major Business
Table 87. Array BioPharma Targeted Drugs for Colorectal Cancer Product and Services
Table 88. Array BioPharma Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Array BioPharma Recent Developments/Updates
Table 90. Array BioPharma Competitive Strengths & Weaknesses
Table 91. Genentech Basic Information, Manufacturing Base and Competitors
Table 92. Genentech Major Business
Table 93. Genentech Targeted Drugs for Colorectal Cancer Product and Services
Table 94. Genentech Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Genentech Recent Developments/Updates
Table 96. Genentech Competitive Strengths & Weaknesses
Table 97. Bayer Basic Information, Manufacturing Base and Competitors
Table 98. Bayer Major Business
Table 99. Bayer Targeted Drugs for Colorectal Cancer Product and Services
Table 100. Bayer Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Bayer Recent Developments/Updates
Table 102. Bayer Competitive Strengths & Weaknesses
Table 103. Sanofi Basic Information, Manufacturing Base and Competitors
Table 104. Sanofi Major Business
Table 105. Sanofi Targeted Drugs for Colorectal Cancer Product and Services
Table 106. Sanofi Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Sanofi Recent Developments/Updates
Table 108. Sanofi Competitive Strengths & Weaknesses
Table 109. Lilly Basic Information, Manufacturing Base and Competitors
Table 110. Lilly Major Business
Table 111. Lilly Targeted Drugs for Colorectal Cancer Product and Services
Table 112. Lilly Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. Lilly Recent Developments/Updates
Table 114. Lilly Competitive Strengths & Weaknesses
Table 115. Bristol myers squibb Basic Information, Manufacturing Base and Competitors
Table 116. Bristol myers squibb Major Business
Table 117. Bristol myers squibb Targeted Drugs for Colorectal Cancer Product and Services
Table 118. Bristol myers squibb Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. Bristol myers squibb Recent Developments/Updates
Table 120. Bristol myers squibb Competitive Strengths & Weaknesses
Table 121. MSD lreland Basic Information, Manufacturing Base and Competitors
Table 122. MSD lreland Major Business
Table 123. MSD lreland Targeted Drugs for Colorectal Cancer Product and Services
Table 124. MSD lreland Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. MSD lreland Recent Developments/Updates
Table 126. HUTCHMED Basic Information, Manufacturing Base and Competitors
Table 127. HUTCHMED Major Business
Table 128. HUTCHMED Targeted Drugs for Colorectal Cancer Product and Services
Table 129. HUTCHMED Targeted Drugs for Colorectal Cancer Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 130. Global Key Players of Targeted Drugs for Colorectal Cancer Upstream (Raw Materials)
Table 131. Targeted Drugs for Colorectal Cancer Typical Customers
Table 132. Targeted Drugs for Colorectal Cancer Typical Distributors
LIST OF FIGURES
Figure 1. Targeted Drugs for Colorectal Cancer Picture
Figure 2. World Targeted Drugs for Colorectal Cancer Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Targeted Drugs for Colorectal Cancer Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 5. World Targeted Drugs for Colorectal Cancer Average Price (2018-2029) & (US$/Unit)
Figure 6. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Region (2018-2029)
Figure 7. World Targeted Drugs for Colorectal Cancer Production Market Share by Region (2018-2029)
Figure 8. North America Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 9. Europe Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 10. China Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 11. Japan Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 12. Targeted Drugs for Colorectal Cancer Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 15. World Targeted Drugs for Colorectal Cancer Consumption Market Share by Region (2018-2029)
Figure 16. United States Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 17. China Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 18. Europe Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 19. Japan Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 20. South Korea Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 22. India Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Targeted Drugs for Colorectal Cancer Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Targeted Drugs for Colorectal Cancer Markets in 2022
Figure 26. United States VS China: Targeted Drugs for Colorectal Cancer Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Targeted Drugs for Colorectal Cancer Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Targeted Drugs for Colorectal Cancer Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share 2022
Figure 30. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share 2022
Figure 32. World Targeted Drugs for Colorectal Cancer Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Type in 2022
Figure 34. EGFR Target
Figure 35. BRAF Target
Figure 36. MEK1/2 Targets
Figure 37. BRAF V600 Target
Figure 38. HER2 Target
Figure 39. VEGFR-1/2/3 Targets
Figure 40. PD-1 Target
Figure 41. CTLA-4 Target
Figure 42. World Targeted Drugs for Colorectal Cancer Production Market Share by Type (2018-2029)
Figure 43. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Type (2018-2029)
Figure 44. World Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029) & (US$/Unit)
Figure 45. World Targeted Drugs for Colorectal Cancer Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 46. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Application in 2022
Figure 47. Hospital
Figure 48. Specialty Clinic
Figure 49. World Targeted Drugs for Colorectal Cancer Production Market Share by Application (2018-2029)
Figure 50. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Application (2018-2029)
Figure 51. World Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029) & (US$/Unit)
Figure 52. Targeted Drugs for Colorectal Cancer Industry Chain
Figure 53. Targeted Drugs for Colorectal Cancer Procurement Model
Figure 54. Targeted Drugs for Colorectal Cancer Sales Model
Figure 55. Targeted Drugs for Colorectal Cancer Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
Figure 1. Targeted Drugs for Colorectal Cancer Picture
Figure 2. World Targeted Drugs for Colorectal Cancer Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Targeted Drugs for Colorectal Cancer Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 5. World Targeted Drugs for Colorectal Cancer Average Price (2018-2029) & (US$/Unit)
Figure 6. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Region (2018-2029)
Figure 7. World Targeted Drugs for Colorectal Cancer Production Market Share by Region (2018-2029)
Figure 8. North America Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 9. Europe Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 10. China Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 11. Japan Targeted Drugs for Colorectal Cancer Production (2018-2029) & (K Units)
Figure 12. Targeted Drugs for Colorectal Cancer Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 15. World Targeted Drugs for Colorectal Cancer Consumption Market Share by Region (2018-2029)
Figure 16. United States Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 17. China Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 18. Europe Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 19. Japan Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 20. South Korea Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 22. India Targeted Drugs for Colorectal Cancer Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Targeted Drugs for Colorectal Cancer by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Targeted Drugs for Colorectal Cancer Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Targeted Drugs for Colorectal Cancer Markets in 2022
Figure 26. United States VS China: Targeted Drugs for Colorectal Cancer Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Targeted Drugs for Colorectal Cancer Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Targeted Drugs for Colorectal Cancer Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share 2022
Figure 30. China Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Targeted Drugs for Colorectal Cancer Production Market Share 2022
Figure 32. World Targeted Drugs for Colorectal Cancer Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Type in 2022
Figure 34. EGFR Target
Figure 35. BRAF Target
Figure 36. MEK1/2 Targets
Figure 37. BRAF V600 Target
Figure 38. HER2 Target
Figure 39. VEGFR-1/2/3 Targets
Figure 40. PD-1 Target
Figure 41. CTLA-4 Target
Figure 42. World Targeted Drugs for Colorectal Cancer Production Market Share by Type (2018-2029)
Figure 43. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Type (2018-2029)
Figure 44. World Targeted Drugs for Colorectal Cancer Average Price by Type (2018-2029) & (US$/Unit)
Figure 45. World Targeted Drugs for Colorectal Cancer Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 46. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Application in 2022
Figure 47. Hospital
Figure 48. Specialty Clinic
Figure 49. World Targeted Drugs for Colorectal Cancer Production Market Share by Application (2018-2029)
Figure 50. World Targeted Drugs for Colorectal Cancer Production Value Market Share by Application (2018-2029)
Figure 51. World Targeted Drugs for Colorectal Cancer Average Price by Application (2018-2029) & (US$/Unit)
Figure 52. Targeted Drugs for Colorectal Cancer Industry Chain
Figure 53. Targeted Drugs for Colorectal Cancer Procurement Model
Figure 54. Targeted Drugs for Colorectal Cancer Sales Model
Figure 55. Targeted Drugs for Colorectal Cancer Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source
